Login | New Member? Signup Free
ChangeDetect » News

Q&A: What is the Impact of Myriad Patent Rulings on IP Landscape for Protein Biomarker-Based Tests?

The decision ruled that isolated gene sequences such as those used by Myriad in BRACAnalysis are not products of nature and are therefore patentable. (8 hours ago)

Tags: , , ,

Appeals Court Decides Isolated Dna Patentable, Myriad’s Analytical Method Claims Not

While ruling that isolated gene sequences are not products of nature and are therefore patentable, the Court of Appeals for the Federal Circuit today decided that Myriad Genetics’ method claims for “comparing” and “analyzing” gene sequences did not meet the criteria for patent eligibility. (6 hours ago)

Tags: , , , , ,